Anti-tumor vaccine efficacy depends on adjuvant type and associates with induced IgG subclass and glycosylation profiles.

Saved in:
Bibliographic Details
Title: Anti-tumor vaccine efficacy depends on adjuvant type and associates with induced IgG subclass and glycosylation profiles.
Authors: Lehrian, Selina1 (AUTHOR), Wasynczuk, Anna2 (AUTHOR), Petry, Janina1 (AUTHOR), Guderian, Melanie3 (AUTHOR), Nouta, Jan2 (AUTHOR), Buhre, Jana Sophia1 (AUTHOR), Lunding, Hanna B.1 (AUTHOR), Köcher, Philipp1 (AUTHOR), Schumacher, Hannah Franziska1 (AUTHOR), Dühring, Lara1 (AUTHOR), Kurwahn, Kathleen4 (AUTHOR), Manzhula, Kristina1 (AUTHOR), Manz, Rudolf4 (AUTHOR), Bartsch, Yannic C.3 (AUTHOR), Wuhrer, Manfred2 (AUTHOR), Ehlers, Marc1,5 (AUTHOR) marc.ehlers@uksh.de
Source: Experimental Hematology & Oncology. 10/6/2025, Vol. 14 Issue 1, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21623619
DOI:10.1186/s40164-025-00708-6